151 related articles for article (PubMed ID: 27793022)
1. Clinical outcomes of advanced-stage glassy cell carcinoma of the uterine cervix: a need for reappraisal.
Yoon N; Kim JY; Kim HS
Oncotarget; 2016 Nov; 7(48):78448-78454. PubMed ID: 27793022
[TBL] [Abstract][Full Text] [Related]
2. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
[TBL] [Abstract][Full Text] [Related]
4. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
6. Glassy cell carcinoma of the cervix revisited.
Gray HJ; Garcia R; Tamimi HK; Koh WJ; Goff BA; Greer BE; Paley PJ
Gynecol Oncol; 2002 May; 85(2):274-7. PubMed ID: 11972387
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
[TBL] [Abstract][Full Text] [Related]
8. [Isolated pelvic recurrences of cervical carcinoma treated with salvage chemoradiotherapy].
Besson N; Touboul E; Daraï É; Lefranc JP; Monnier L; Schlienger M; Huguet F
Cancer Radiother; 2014 Mar; 18(2):83-8. PubMed ID: 24462252
[TBL] [Abstract][Full Text] [Related]
9. Glassy cell carcinoma of the uterine cervix.
Piura B; Rabinovich A; Meirovitz M; Yanai-Inbar I
J Surg Oncol; 1999 Dec; 72(4):206-10. PubMed ID: 10589035
[TBL] [Abstract][Full Text] [Related]
10. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
11. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
Resbeut M; Cowen D; Viens P; Noirclerc M; Perez T; Gouvernet J; Delpero JR; Gamerre M; Boubli L; Houvenaeghel G
Gynecol Oncol; 1994 Jul; 54(1):68-75. PubMed ID: 8020842
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of concurrent chemoradiotherapy with weekly carboplatin in locally-advanced carcinoma of the uterine cervix patients.
Sangkittipaiboon S
J Med Assoc Thai; 2014 Jan; 97(1):12-9. PubMed ID: 24701724
[TBL] [Abstract][Full Text] [Related]
14. Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy.
Pérez-Regadera J; Sánchez-Muñoz A; De-la-Cruz J; Ballestín C; Lora D; García-Martín R; Sotoca A; Pérez-Ruiz E; Lanzós E
Am J Clin Oncol; 2011 Aug; 34(4):395-400. PubMed ID: 20859196
[TBL] [Abstract][Full Text] [Related]
15. Multimodal treatment for glassy cell carcinoma of the uterine cervix.
Nasu K; Takai N; Narahara H
J Obstet Gynaecol Res; 2009 Jun; 35(3):584-7. PubMed ID: 19527406
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
17. Glassy cell carcinoma of the uterine cervix a rare histology. Report of three cases with a review of the literature.
Deshpande AH; Kotwal MN; Bobhate SK
Indian J Cancer; 2004; 41(2):92-5. PubMed ID: 15318016
[TBL] [Abstract][Full Text] [Related]
18. Large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathological study of six cases.
Sato Y; Shimamoto T; Amada S; Asada Y; Hayashi T
Int J Gynecol Pathol; 2003 Jul; 22(3):226-30. PubMed ID: 12819387
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes observation in stage IIB-IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy.
Li Y; Chen Z; Wang X; Li X; Zhou J; Zhang Y
BMC Cancer; 2021 Apr; 21(1):442. PubMed ID: 33882876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
